Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment

By sjmartinez • January 18, 2025

Gorelick J, Nguyen A, Schneider SKR, Martel BC, Madsen DE, Armstrong AW. Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment. Am J Clin Dermatol. 2025 Jan 16. doi: 10.1007/s40257-024-00913-9. Epub ahead of print. PMID: 39820896.

Tags: Dermatology, Publications

A scalp to make you squirm: Cutaneous myiasis hiding a unique presentation of disseminated coccidioidomycosis

Duldulao JM, Modanlo N, Boppana S, Adachi K, Dong HV, Kaur I, Nielsen-Saines K, Terrell J, Cheng CE, Malhotra S. A scalp to make you[...]

Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals

Matthews R, Armstrong AW, Augustin M, Baker C, Carrascosa JM, Kirby B, Langley R, McBride S, Reich A, Romiti R, Sampogna F, Warren RB. Is[...]

T cell-macrophage interactions in tuberculosis: What we’ve got here is failure to communicate

Mortensen R, Arlehamn CSL, Coler RN, Gerner MY, Goletti D, Lewinsohn DA, Modlin RL, Musvosvi M, Rengarajan J, Urdahl KB, Walzl G, Behar SM, Barber[...]